Radioactive iodine therapy in patients with thyroid carcinoma with distant metastases: a SEER-based study
C Li, Q Wu, S Sun - Cancer control, 2020 - journals.sagepub.com
Distant metastasis (DM) is the dominant negative prognosis for thyroid carcinoma.
Radioactive iodine (RAI) therapy serves as an effective treatment for thyroid carcinoma …
Radioactive iodine (RAI) therapy serves as an effective treatment for thyroid carcinoma …
Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: an 8-year retrospective study
R Wang, Y Zhang, J Tan, G Zhang, R Zhang, W Zheng… - Medicine, 2017 - journals.lww.com
To assess the efficacy of radioiodine therapy (RIT) and investigate the prognostic factors for
patients with pulmonary metastasis secondary to differentiated thyroid carcinoma (DTC) …
patients with pulmonary metastasis secondary to differentiated thyroid carcinoma (DTC) …
The importance of age over radioiodine avidity as a prognostic factor in differentiated thyroid carcinoma with distant metastases
J Mihailovic, L Stefanovic, M Malesevic, B Markoski - Thyroid, 2009 - liebertpub.com
Background: Differentiated thyroid carcinoma (DTC) usually has a good prognosis and
rarely develops distant metastases. Although it might be expected that avid radioiodine …
rarely develops distant metastases. Although it might be expected that avid radioiodine …
Prognosis and prognostic factors of differentiated thyroid carcinoma after the appearance of metastasis refractory to radioactive iodine therapy
Y Ito, A Miyauchi, M Ito, T Yabuta, H Masuoka… - Endocrine …, 2014 - jstage.jst.go.jp
Differentiated thyroid carcinomas (DTCs) are generally indolent, but few therapeutic
strategies are available after a metastatic recurrence that is refractory to radioactive iodine …
strategies are available after a metastatic recurrence that is refractory to radioactive iodine …
Association of the cumulative dose of radioactive iodine therapy with overall survival in patients with differentiated thyroid cancer and pulmonary metastases
J Yang, R Zheng, M Liang, Y Jia, L Lin, J Geng… - Frontiers in …, 2019 - frontiersin.org
Purpose: The optimal cumulative dose of radioactive iodine therapy (RAIT) for patients with
differentiated thyroid cancer (DTC) and pulmonary metastases (PM) is not known, therefore …
differentiated thyroid cancer (DTC) and pulmonary metastases (PM) is not known, therefore …
Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature
X Zhang, DS Liu, ZS Luan, F Zhang, XH Liu… - Clinical and …, 2018 - Springer
Background Radioiodine therapy (RAI) after total or near-total thyroidectomy is a
recommended treatment for patients with pulmonary metastasis from differentiated thyroid …
recommended treatment for patients with pulmonary metastasis from differentiated thyroid …
Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors
HJ Song, ZL Qiu, CT Shen, WJ Wei… - European Journal of …, 2015 - academic.oup.com
Context Data from a large cohort of patients with pulmonary metastases from differentiated
thyroid cancer (DTC) were retrospectively analyzed. Objective To assess the effect of …
thyroid cancer (DTC) were retrospectively analyzed. Objective To assess the effect of …
Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma
XY Zhang, JW Sun, ZL Qiu, Y Wang, XY Chen, JH Zhao… - Endocrine, 2019 - Springer
Objectives For patients with differentiated thyroid carcinoma (DTC), distant metastases are
commonly identified in the lungs and bones. However, they are relatively rare in other …
commonly identified in the lungs and bones. However, they are relatively rare in other …
Long-term outcomes and prognostic factors in patients with differentiated thyroid cancer and distant metastases
D Hirsch, S Levy, G Tsvetov, A Gorshtein… - Endocrine Practice, 2017 - Elsevier
Objective: Distant metastatic spread is the most frequent cause of thyroid cancer-related
death. The objective of this study was to evaluate overall and disease-related survival of …
death. The objective of this study was to evaluate overall and disease-related survival of …
Clinical management and outcomes in patients with hyperfunctioning distant metastases from differentiated thyroid cancer after total thyroidectomy and radioactive …
ZL Qiu, CT Shen, QY Luo - Thyroid, 2015 - liebertpub.com
Background: Hyperfunctioning distant metastasis (HFDM) from differentiated thyroid cancer
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …
(DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting …
相关搜索
- distant metastases thyroid carcinoma
- thyroid cancer pulmonary metastases
- iodine therapy thyroid carcinoma
- radioiodine therapy pulmonary metastases
- radioiodine therapy thyroid cancer
- iodine therapy distant metastases
- distant metastases radioiodine treatment
- distant metastases prognostic factor
- distant metastases importance of age
- iodine therapy overall survival
- importance of age thyroid carcinoma
- radioiodine treatment thyroid carcinoma
- prognostic factor thyroid carcinoma
- side effects thyroid carcinoma
- meta analysis pulmonary metastases
- meta analysis thyroid cancer